MAM
Zoop from Titan launches the Puss in Boots collection
MUMBAI: The Zoop brand from Titan stable has launched Puss in Boots inspired watches to celebrate the release of the animation film.
The collection comprises of eight watches inspired by Puss in Boots and Kitty Softpaws, the protagonists of the movie. Titan will also launch various watches featuring Shrek and Donkey from the Shrek movies.
Titan senior manager marketing Somprabh Singh said, “Puss in Boots is a very popular character amongst children. The audience embraced Puss in Boots in the Shrek films, and Zoop has brought the character alive in its new range of watches. The Puss in Boots collection personifies the dashing and mysterious persona of Puss in Boots and the mischievous and vivacious attitude of Kitty Softpaws. We’re also excited to be able to feature watches dedicated to the fun and evergreen elements of Shrek and his pal Donkey.”
The watches come in colours like eclectic blue, red and pink, and are priced between Rs 395 and Rs 595.
The dials are inspired by various facets of these characters while the straps come in appealing colours and are made of non-abrasive material marked by the quality hallmark of Titan.
The Puss in Boots collection and the Shrek watches are available in all World of Titan outlets, key multi-brand outlets and large format stores across the country.
The deal was brokered by DreamWorks Animation’s licensing agent in India Dream Theatre.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
